Quotes Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG
Equities
GHDN
US10501E2019
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.355 EUR | -0.28% | -5.96% | +54.35% |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG24/06/2024 | 25/06/2024 | 26/06/2024 | 27/06/2024 | |
---|---|---|---|---|
Last | 0.3415 € | 0.3445 € | 0.356 € | 0.355 € |
Change | -2.71% | +0.88% | +3.34% | -0.28% |
Performance
1 day | -0.28% | ||
1 week | -5.96% | ||
Current month | -25.26% | ||
1 month | -26.88% | ||
3 months | -30.39% | ||
6 months | +82.05% | ||
Current year | +54.35% | ||
1 year | -81.70% | ||
3 years | -88.91% | ||
5 years | -89.48% | ||
10 years | -82.47% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.28% | -5.96% | +54.35% | -81.70% | 27.42M | ||
-1.04% | -9.84% | +21.85% | +0.42% | 46.93B | ||
+0.10% | +1.29% | +37.63% | -5.59% | 39.08B | ||
+0.74% | -0.67% | -8.05% | -0.89% | 38.48B | ||
+0.75% | +56.93% | +29.04% | +30.83% | 31.01B | ||
-1.70% | -3.50% | -13.75% | +15.25% | 26.14B | ||
+0.08% | -0.88% | +10.65% | +36.83% | 25.88B | ||
+4.69% | +5.92% | +38.43% | +90.28% | 12.53B | ||
-0.39% | -3.64% | -6.92% | -4.99% | 11.36B | ||
+0.31% | -1.09% | -12.29% | +1.48% | 10.65B | ||
+0.91% | -1.89% | -8.20% | -10.81% | 9.04B | ||
-0.99% | +15.73% | -6.64% | +19.99% | 6.96B | ||
+2.53% | +3.88% | +27.62% | +10.60% | 6.76B | ||
+4.43% | +3.15% | +17.65% | +72.28% | 6.51B | ||
+0.29% | +2.64% | +34.34% | +50.10% | 6.34B | ||
-.--% | -.--% | - | - | 6.07B | ||
Average | +0.65% | +4.77% | +14.38% | +14.94% | ||
Weighted average by Cap. | +0.25% | +5.26% | +13.24% | +14.64% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +54.35% | ||
2023 | -83.25% | ||
2022 | -60.30% | ||
2021 | -9.90% | ||
2020 | +6.67% | ||
2019 | +29.03% | ||
2018 | +12.27% | ||
2017 | +22.72% | ||
2012 | +12.50% | ||
2011 | +27.66% | ||
2010 | -45.66% | ||
2009 | +214.55% | ||
2008 | -86.90% | ||
2007 | +110.00% | ||
2006 | -50.00% | ||
2005 | -69.23% | ||
2004 | +160.00% |
- Stock Market
- Equities
- BCLI Stock
- GHDN Stock
- Quotes Brainstorm Cell Therapeutics Inc.